|
1
|
Sachdeva AK, Kuhad A and Chopra K:
Naringin ameliorates memory deficits in experimental paradigm of
Alzheimer's disease by attenuating mitochondrial dysfunction.
Pharmacol Biochem Behav. 127:101–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ballatore C, Lee VM and Trojanowski JQ:
Tau-mediated neurodegeneration in Alzheimer's disease and related
disorders. Nat Rev Neurosci. 8:663–672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Auld DS, Kornecook TJ, Bastianetto S and
Quirion R: Alzheimer's disease and the basal forebrain cholinergic
system: Relations to beta-amyloid peptides, cognition, and
treatment strategies. Prog Neurobiol. 68:209–245. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Honjo H, Iwasa K, Kawata M, Fushiki S,
Hosoda T, Tatsumi H, Oida N, Mihara M, Hirasugi Y, Yamamoto H, et
al: Progestins and estrogens and Alzheimer's disease. J Steroid
Biochem Mol Biol. 93:305–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao Y, Li C, Yin J, Shen J, Wang H, Wu Y
and Jin H: Fucoidan, a sulfated polysaccharide from brown algae,
improves cognitive impairment induced by infusion of Aβ peptide in
rats. Environ Toxicol Pharmacol. 33:304–311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hampel H, Blennow K, Shaw LM, Hoessler YC,
Zetterberg H and Trojanowski JQ: Total and phosphorylated tau
protein as biological markers of Alzheimer's disease. Exp Gerontol.
45:30–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferreira-Vieira TH, Guimaraes IM, Silva FR
and Ribeiro FM: Alzheimer's disease: Targeting the cholinergic
system. Curr Neuropharmacol. 14:101–115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Medina M: Recent developments in tau-based
therapeutics for neurodegenerative diseases. Recent Pat CNS Drug
Discov. 6:20–30. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He LY, He XH, Pang GF, Liang QH, Yang Z
and Hu CY: The pathogenesis and treatment of Alzheimer's disease.
Chin Geriatric Care Med. 15:12–14. 2017.(In Chinese).
|
|
10
|
Chen L and DiWu YC: Research progress on
the relationship between hippocampal nerve cell senescence and
neurogenesis and Alzheimer's disease. Hebei J Tradit Chin Med.
39:1583–1587. 2017.(In Chinese).
|
|
11
|
Guzior N, Wieckowska A, Panek D and
Malawska B: Recent development of multifunctional agents as
potential drug candidates for the treatment of Alzheimer's disease.
Curr Med Chem. 22:373–404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu ZL, Xu MY, Wang HT, Xu QX, Liu MY, Jia
CP, Geng F and Zhang N: Pharmacokinetics of eight flavonoids in
rats assayed by UPLC-MS/MS after oral administration of
Drynariae rhizoma extract. J Anal Methods Chem.
2018:47891962018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Z, Kuboyama T and Tohda C: A
Systematic strategy for discovering a therapeutic drug for
Alzheimer's disease and its target molecule. Front Pharmacol.
8:3402017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen R, Qi QL, Wang MT and Li QY:
Therapeutic potential of naringin: An overview. Pharm Biol.
54:3203–3210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Golechha M, Sarangal V, Bhatia J, Chaudhry
U, Saluja D and Arya DS: Naringin ameliorates
pentylenetetrazol-induced seizures and associated oxidative stress,
inflammation, and cognitive impairment in rats: Possible mechanisms
of neuroprotection. Epilepsy Behav. 41:98–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Golechha M, Chaudhry U, Bhatia J, Saluja D
and Arya DS: Naringin protects against kainic acid-induced status
epilepticus in rats: Evidence for an antioxidant, anti-inflammatory
and neuroprotective intervention. Biol Pharm Bull. 34:360–365.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kumar P and Kumar A: Protective effect of
hesperidin and naringin against 3-nitropropionic acid induced
Huntington's like symptoms in rats: Possible role of nitric oxide.
Behav Brain Res. 206:38–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao W, Feng SJ and Kan MC: Naringin
targets NFKB1 to alleviate oxygen-glucose
deprivation/reoxygenation-induced injury in PC12 cells via
modulating HIF-1α/AKT/mTOR-signaling pathway. J Mol Neurosci.
71:101–111. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang DM, Yang YJ, Zhang L, Zhang X, Guan
FF and Zhang LF: Naringin enhances CaMKII activity and improves
long-term memory in a mouse model of Alzheimer's disease. Int J Mol
Sci. 14:5576–5586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li C, Wang H and Wang L: Replication of a
rat model of renal insufficiency Alzheimer's disease. J Anhui Coll
Tradit Chin Med. 32:62–67. 2013.(In Chinese).
|
|
21
|
Mathiasen JR and DiCamillo A: Novel object
recognition in the rat: A facile assay for cognitive function. Curr
Protoc Pharmacol Chapter. 5:Unit 5.59. 2010.
|
|
22
|
Gao Y, Yin H, Zhang Y, Dong Y, Yang F, Wu
X and Liu H: Dexmedetomidine protects hippocampal neurons against
hypoxia/reoxygenation-induced apoptosis through activation
HIF-1α/p53 signaling. Life Sci. 232:1166112019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bolt D, Giger R, Wirth S and Swanenburg J:
Step-down test assessment of postural stability in patients with
chronic ankle instability. J Sport Rehabil. 27:2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kimura A, Hata S and Suzuki T: Alternative
selection of β-site APP-cleaving enzyme 1 (BACE1) cleavage sites in
amyloid β-protein precursor (APP) harboring protective and
pathogenic mutations within the Aβ sequence. J Biol Chem.
291:24041–24053. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Holtzman DM, Morris JC and Goate AM:
Alzheimer's disease: The challenge of the second century. Sci
Transl Med. 3:77sr12011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ali MY, Jannat S, Edraki N, Das S, Chang
WK, Kim HC, Park SK and Chang MS: Flavanone glycosides inhibit
β-site amyloid precursor protein cleaving enzyme 1 and
cholinesterase and reduce Aβ aggregation in the amyloidogenic
pathway. Chem Biol Interact. 309:1087072019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lopes S, Lopes A, Pinto V, Guimarães MR,
Sardinha VM, Duarte-Silva S, Pinheiro S, Pizarro J, Oliveira JF,
Sousa N, et al: Absence of Tau triggers age-dependent sciatic nerve
morphofunctional deficits and motor impairment. Aging Cell.
15:208–216. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saito T, Oba T, Shimizu S, Asada A, Iijima
KM and Ando K: Cdk5 increases MARK4 activity and augments
pathological tau accumulation and toxicity through tau
phosphorylation at Ser262. Hum Mol Genet. 28:3062–3071. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech
W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, et al:
Beta-amyloid oligomers induce phosphorylation of tau and
inactivation of insulin receptor substrate via c-Jun N-terminal
kinase signaling: Suppression by omega-3 fatty acids and curcumin.
J Neurosci. 29:9078–9089. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fan S, Xian X, Li L, Yao X, Hu Y, Zhang M
and Li W: Ceftriaxone improves cognitive function and upregulates
GLT-1-related glutamate-glutamine cycle in APP/PS1 mice. J
Alzheimers Dis. 66:1731–1743. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ashpole NM and Hudmon A: Excitotoxic
neuroprotection and vulnerability with CaMKII inhibition. Mol Cell
Neurosci. 46:720–730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pellegrini-Giampietro DE, Gorter JA,
Bennett MV and Zukin RS: The GluR2 (GluR-B) hypothesis:
Ca(2+)-permeable AMPA receptors in neurological disorders. Trends
Neurosci. 20:464–470. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Caricasole A, Copani A, Caraci F, Aronica
E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G, Terstappen GC
and Nicoletti F: Induction of Dickkopf-1, a negative modulator of
the Wnt pathway, is associated with neuronal degeneration in
Alzheimer's brain. J Neurosci. 24:6021–6027. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jarskog LF, Selinger ES, Lieberman JA and
Gilmore JH: Apoptotic proteins in the temporal cortex in
schizophrenia: High Bax/Bcl-2 ratio without caspase-3 activation.
Am J Psychiatry. 161:109–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lok J and Martin LJ: Rapid subcellular
redistribution of Bax precedes caspase-3 and endonuclease
activation during excitotoxic neuronal apoptosis in rat brain. J
Neurotrauma. 19:815–825. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gu Y, Chen X, Shang C, Singh K, Barzegar
M, Mahdavian E, Salvatore BA, Jiang S and Huang S: Fusarochromanone
induces G1 cell cycle arrest and apoptosis in COS7 and HEK293
cells. PLoS One. 11:e1126412014. View Article : Google Scholar
|
|
37
|
Goodenough S, Schäfer M and Behl C:
Estrogen-induced cell signalling in a cellular model of Alzheimer's
disease. J Steroid Biochem Mol Biol. 84:301–305. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang H, Muiznieks LD, Ghosh P, Williams D,
Solarski M, Fang A, Ruiz-Riquelme A, Pomès R, Watts JC,
Chakrabartty A, et al: Somatostatin binds to the human amyloid β
peptide and favors the formation of distinct oligomers. Elife.
6:e284012017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Torres-Cuevas I, Parra-Llorca A,
Sánchez-Illana A, Nuñez-Ramiro A, Kuligowski J, Cháfer-Pericás C,
Cernada M, Escobar J and Vento M: Oxygen and oxidative stress in
the perinatal period. Redox Biol. 12:674–681. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Amin MM, Rafiei N, Poursafa P, Ebrahimpour
K, Mozafarian N, Shoshtari-Yeganeh B, Hashemi M and Kelishadi R:
Association of benzene exposure with insulin resistance, SOD, and
MDA as markers of oxidative stress in children and adolescents.
Environ Sci Pollut Res Int. 25:34046–34052. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Z, Yu J, Wu J, Qi F, Wang H, Wang Z
and Xu Z: Scutellarin protects cardiomyocyte ischemia-reperfusion
injury by reducing apoptosis and oxidative stress. Life Sci.
157:200–207. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang YX, Tian K, He CC, Ma XL, Zhang F,
Wang HG, An D, Heng B, Jiang YG and Liu YQ: Genistein inhibits
hypoxia, ischemic-induced death, and apoptosis in PC12 cells.
Environ Toxicol Pharmacol. 50:227–233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu XF, Liu F, Xin JQ, Fan JW, Wu N, Zhu
LJ, Duan LF, Li YY and Zhang H: Respective roles of the
mitogen-activated protein kinase (MAPK) family members in
pancreatic stellate cell activation induced by transforming growth
factor-β1 (TGF-β1). Biochem Biophys Res Commun. 501:365–373. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sui X, Kong N, Ye L, Han W, Zhou J, Zhang
Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of
apoptosis and autophagy in response to chemotherapeutic agents.
Cancer Lett. 344:174–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
